K163536

Substantially Equivalent

MALDI Biotyper CA (MBT-CA) System, MBT smart CA System

Applicant: Bruker Daltonik GmbH
Product code: PEX
Advisory panel: Microbiology
Date received: 2016-12-16
Decision date: 2017-07-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bremen, DE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.